Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 287 results.

Selected filters: Physicians

Displaying 31 to 40 of 287 records
Sort by: Page: << Prev 1… 2… 3… 4… 5… 6… 7… Next >>

JNM Outlines the Future of Theranostics in Neurooncology – Feb 15, 2024
Nuclear medicine has the potential to change the landscape of theranostics in neurooncology, according to a new article in JNM. With recent advances in techniques to permeate the brain-blood barrier, the prospect of using radiopharmaceuticals to treat brain tumors is promising.
Radiopharmaceutical Therapy Controls Symptoms and Reduces Medications in Insulinoma Patients – Feb 12, 2024
PRRT is effective for clinical control of symptomatic metastatic insulinomas, according to new research published in JNM. In the largest study to date of metastatic insulinoma patients treated with PRRT, more than 80 percent of patients had long-lasting symptom control, and nearly 60 percent were able to reduce the use of other drugs to treat the disease.
New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear – Feb 8, 2024
A novel PET imaging technique can noninvasively detect active inflammation in the body such as rheumatoid arthritisbefore clinical symptoms arise, according to research published in JNM.
SNMMI Mid-Winter and ACNM Annual Meeting Highlights Advances in Nuclear Medicine and Molecular Imaging – Feb 5, 2024
More than 700 attendees from around the world gathered in Orlando, Florida, on February 1-3 for the SNMMI Mid-Winter and ACNM Annual Meeting.
New PET/CT Technique Accurately Diagnoses Adrenal Gland Disorder, Informs Personalized Treatment Plans – Jan 18, 2024
A novel imaging approach, Ga-68 pentixafor PET/CT, has been shown to accurately identify sub-types of primary aldosteronism, outperforming traditional methods for diagnosis, according to research published in JNM.
Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer, Offers Potential for Targeted Therapy – Jan 11, 2024
A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer in preclinical and clinical studies, according to research published in JNM.
JNM Publishes Procedure Standard/Practice Guideline for FES PET Imaging of Breast Cancer – Jan 5, 2024
SNMMI and EANM have issued a new procedure standard/practice guideline for estrogen receptor imaging of breast cancer patients using FES PET.
Ga-68 FAPI PET Improves Detection and Staging of Pancreatic Cancer – Dec 20, 2023
PET imaging with Ga-68 FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in JNM. In addition, Ga-68 FAPI imaging paves the way for future targeted radiopharmaceutical therapies.
New PET Tracer Noninvasively Identifies Cancer Gene Mutation, Allows for More Precise Diagnosis and Therapy – Dec 19, 2023
A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy, according to research published in The Journal of Nuclear Medicine.
HPRA December 2023 Newsletter – Dec 14, 2023
SNMMI Health Policy and Regulatory Affairs Department released its December 2023 Newsletter. Highlights include updates on CMS HOPPS Rules, The FIND Act, and other legislative initiatives.

Displaying 31 to 40 of 287 records
Page: << Prev 1… 2… 3… 4… 5… 6… 7… Next >>